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p53 expression was studied immunohistochemically 
to identify a precursor lesion of basal cell carcinoma 
(BCC) in the epidermis adjacent to BCC. With two 
different anti-p53 antibodies of CM1 and D07, p53 
expression was frequently detected in the epidermis 
adjacent to BCCs arising on the face and in the 
normal epidermis with usual sun exposure. In the 
epidennis adjacent to BCC, stained cells were occa-
sionally clustered in a small area, but no cluster was 
found in the normal epidermis with usual sun expo-
sure. The expression was less frequent in the normal 
epidermis with rare sun exposure. Ten cases of nor-
mal skin with usual sun exposure, showing CM1 
staining in the epidermis, were screened for p53 gene 
mutations with polymerase chain reaction-single-
strand conformation polymorphism analysis using 
DNAs obtained from the epidermis. No mutation was 
I t is widely accepted that tumorigenesis is a multistep process that involves activation of proto oncogenes and inactivation of tumor-suppressor genes [1, 2]. Thjs process has been bes t understood in colorectal cancer in which the histopatho-logic progression is often correlated with specific genetic 
changes [3]. Alterations of the ps3 tumor-suppressor gene, which 
are the m ost common genetic chan ges in various types of tumors 
[4], frequentl y occur at a late stage in colorectal carcinogenesis. 
Mutatio ns in the ps3 gene ha ve also been often de tected in basal 
cell carcin o m a (BCC) of the skin [5-10]. Epidemiologic observa-
tions that ultraviolet (UV) light is involved in carcinogenesis o f 
BCC [11] have been supported at a molecular level by predo minant 
mutations of C to T transitions at dipyrimidine sites, including CC 
to TT substitutions, in BCe. Although relevance of ps3 gene 
mutations to carcinogenesis of BCC has been indi ca ted , whether 
ps3 mutatio ns occur as an early event o r a late event of the 
carcinogenesis remains to be answered . It may be difficult to clarify 
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detected in exons 2 to 10 of the p53 gene in these 10 
cases. The epidermis flanking three BCCs that was 
stained with CM1, on the other hand, carried a 
missense mutation of C to G transversion at a dipyri-
midine site of codon 249. This alteration replaced 
arginine with threonine. The mutation of codon 249 
was not detected in the three BCCs. Our results first 
suggest that ultraviolet light irradiating the skin in a 
daily life induces p53 accumulation in the epidermis 
and secondly that the frequent clonal expansion of 
p53 mutant cells occurs in the epidermis adjacent to 
BCCs. This clonal expansion of mutant p53 may 
provide a molecular basis for high risk of developing 
subsequent new skin cancers in patients with BCC. 
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this, because th e majority of BCCs do not arIse from precursor 
lesions but rather appear de 11.0 1)0 [12]. 
Immunohistochemical detection of ps3 proteins has becom e a 
common approach to assess potenti al ps3 mutations' in tumors [1 3]. 
The accumulation of ps3 has been thoug ht to be m ainly ca used by 
elongated half-lives of the proteins caused by mutations [1 4] , 
although recent evidence suggests that th e correlation between 
immunohistochemical overexpression and underlying mutations is 
not absolute [9 ,10,15] and that there are other m echanisms for the 
accumulation by DNA damaging agents including UV ligh t [1 6 -
18] . Immunohistochemical overexpression of ps3 has been ob-
served not o nly in invasive tumors but also in precanceroll s or early 
lesions of tumors of the skin [19 -21] . Overexpression of ps3 might 
be a useful marker to identify precursor les io ns of ca ncers arising de 
110 ')0, which are histopathologically indistinguishable from normal 
cells. In the present study, ps3 expressio n in the epidermis adjacent 
to BCC w as immunohistochemicaUy examined because precursor 
lesions of BCC might be identified by ps3 staining . In samples 
showing immunostaining in the epidermis, ps3 gene mutations 
were screened by polymerase chain reaction-sin gle-strand con for-
m ation polymorphism (PCR-SSCP) analysis usin g epidermal DN As 
obtained from microdissected tissue materi als . M ll tated seque nces 
were confirmed by DNA sequencin g. Our resu lts indicated clonal 
expan sio n of ps3 mutant cell s in the epidermis adjacent to BeC, 
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Table I. ImmunohistochCluical p53 Expression in Normal Skin and Basal Cell Carcinoma 
Number of Specimens Stained with 
Number of 
Age M ean Sex Site Specimens C Ml p" D07 p" 
Specimens (range) (F/M) Examined Examined (%) Value (%) Value 
Normal epide rmis Face 11 8 (73) 5 (45) 
Scalp 3 2 (67) 2 (67) 
U sual sun exposure 41 (1-67) 4/12 Ear 2 1 (50) o (0) 
Total 16 11 (69) < 0.05 7 (44) < 0.05 
Trunk 8 1 (13) o (0) 
Ra re sun exposure 47 (3-87) 7/4 Buttock 2 1 (50) o (0) 
Sole 0(0) o (0) 
Tota l 11 2 (12) o (0) 
Basal cell ca rcinoma 
TUI110r 69 (51-91) 1116 Face 17 15 (88) 11 (65) 
Adjacent epidermis 69 (51-91) 11 /6 Face 17 11 (65) < 0 .05 7 (41) < 0 .05 
.. The freq uell c), showing imlllullo llistochclllical staining in the normal epidermis with usual sun exposure :1Ild that in the cpidcnnis adjacent to Bee were statisticaJl y compa red 
'with that in the epidermis w ith rare sun exposure using the chi-square tcst. Valu es llsed for the comparison arc freque ncies in total cases. 
providing a p ossible m o lecular basis fo r the hig h risk for subsequent 
skin can cers in patie nts w ith BCC. 
MATERJ ALS AND METH ODS 
Specintens A total of 44 specimens (8 mm in diameter) were obtained 
fro m 43 Japanese patients. Details of specimens arc summarized in Table I. 
Seventeen samples of BCC cons isted of 13 of a solid type and four of an 
adenoid type. N o BCC pa tients had received chemotherapy. Twenty-seven 
samples of the nonnal skin were obtai ned from 26 patients undergoing 
plastic surgery. The specimens were quickly fi'ozen in liquid nitrogen and 
stored at -70°C until usc. 
hnntullohistochemistry A mouse mo noclonal anti-p53 antibody of 
D07 (Novocastra Laboratory, N ewcastle-upon-Tyne, UK) , and a rabbit 
polyclo nal anti-p53 antiserum of C M 1 (Novocastra Laboratory) were used 
as primary an tibodies to detect p53 . D07 and CM1 were applied at dilutions 
of 1:100 and 1 :1 500 as recommended by the supplier. respectively. Frozen 
6-fJ.m-thick sections were fixed with 4% parafo1111aldehyde in 0.1 M 
phosphate buffer, pH 7.4. fo r 30 min at 4°C. Fixed sections were immu-
nosta ined by an avidin-biotin-peroxidase complex m ethod as previously 
described [22]. The sections were countersta ined with m ethyl green . As 
positive con trols for the immunostaining, we used a SV40-transfo rl11ed 
human lung fIbrob last cell line, Wl-38 VAl 3 sub2 RA, supplied by 
Japanese Can cer R esearch R esources Bank. and a hUlllan cutaneous 
squamous cell carcinoma cell line established in this labo ratory. which 
abundantly expressed 1'53 (data not shown). As nega ti ve contro ls fo r the 
immunosta ining. we used no rmal Illouse IgG (10 fJ.g/ ml) instead of D07, 
and normal rabbi t sel'llm (1 :1500 di lution) instead of C Ml . In comparison 
with negative controls. clearly sta ined nuclei were regarded as spec ifi c 
sta ining. Cases sho \vi ng specific staining \vcrc counted as positive even 
tho ugh stained nucle i were small in number. Specific staining was judged 
independently by three observers (TA. SK, and SS) without prior knowl-
edge of the clinical data . Statistica l analyses w ere ca rried o ut using the 
chi-square test. 
DNA Preparation DNA was prepared as previo usly described [9] . 
BrieRy, DNAs o f the epidermis were prepared from five frozen 6-fJ.m-thick 
sect.io ns 0 11 111icroscopic glass slides, which were consecu tive to th ose llsed 
for immunohistochemical staining . To enrich D NAs of the ep ide rmis 
showing p53 overexpressio n , ep idermal portions co rrespo nding to those 
showing immuno histochemica l p53 staHlIng were microdissected w itl1 a 
needle under ,nicroscopic o bservation . DN As ofBCC were prepared fro m 
portions of tumo r nests m ore tha n 2 mm apart from the ep idennis to avoid 
cross-contamination . To avo id con ta mina tion, tltis step was perfonned 
carefully by usin g a new needle in each section. DNAs of peripheral blood 
cell s from patients were used as tllOse of nom1al tissue . 
PCR-SSCP Analysis and DNA Sequencing Mutations in exons 2 to 
10 of the p53 gene were fIrst screened by PC R-SSCP analysis as previously 
described [9]. O ligonucleotide primers to ampliry exons 2 to 10 arc Li sted in 
Table II . PCR-SSCP was repeated at least twice in each case showing a 
m obili ty shi ft to ensure that th e resul ts were reproducible . Bands with 
altered migration in SSCP analyses were extracted from a gel. re-amplifi ed 
by PCR and cloned into the pCR II vector using a T A cloning kit 
(Invitrogen Co., San Diego, CA). C lo ned D N As were sequenced by 
Ruorescence-based d ideoxy- tennination m ethods using AmpliTaq DNA 
polymerase and an Applied Biosystem s Model 373A automated DNA 
sequencer (Perkin-Elmer/Division of AppLi ed Biosystems, Foste r C ity , CA). 
Detected mutations w ere confirm ed by clirec t seqnencing of re-ampLified 
PC R. products of bands w ith mobility shi ft as previo usly described [9]. 
RESULTS 
Of 17 cases of Bee, 15 (88% ) and 12 (65%) sh owed nuclear 
staining in tum or n ests w ith eM 1 and D07, resp ectively . Of the 17 
cases, 11 (65'Yo) and seven (41 % ) sh owed nuclear staining in t h e 
e pidennis adjacent to Bee w ith eM 1 and 007, resp ectively 
(Table I) . The stain ed cell s were occasionally clustered in small 
areas of the e pidermis (Fig 1). All cases w ith nucl ear staining in the 
epidermis also showed that in tumOr n ests . All cases showing 
reactivity w i t h D07 were stain ed "'lith CM! as well. 
B eca use all BeC specimens examined h e re were obtain ed from 
facial lesions th at were usual ly exposed to sunlight, t h e frequent 
p53 overexpress io n d e tected in t h e e pide rmis adj acent to Bee 
mig ht b e r e late d to chronic UV lig h t exposure. To test this 
p oss ibili ty, p53 expressio n was examined in n orm a l skin o btained 
fro m various sites. Of 16 specim ens obtain e d 6'0111 sites with u su a l 
sun exposure, 11 (69% ) and seven (44% ) sh owed nuclear staining in 
Table II. Oligonucleotide Primers to Amplify Exons 2 to 10 of the p53 Gene 
Exo l1 
2-3 
4 
5 
6 
7" 
8 
9 
10 
Sense Pril11Cr 
5'-AGACTGCCTTCCGGGTCACT-3' 
5' -AGGACCTGGTCCTCTGACTG-3' 
5' -TI"CCTCTTCCTACAGT ACTC-3' 
5' -CACTGA TTGCTCTT AGGTCT -3' 
5' -GTGTT A(G)TCTCCT AGGTTGGC-3 ' 
5'-CCTATCCTGAGTAGTGGTAA- 3' 
5 ' -TTGCCTCTTTCCTAGCACTG-3 , 
5' -CTCTGTTGCTGCAGATCCGT - 3' 
Antisense Prinlcr 
5' -AACCCTTGTCCTTACCAGAA-3 ' 
5'-GCATTGAAGTCTCATGGAAG-3' 
5' -CAGCTGCTCACCATCGCTAT -3 ' 
5 ' -AGTTGCAAACCAGA CTCAG-3' 
5 ' -CAAGTGGCTCCTGAC TGGA-3' 
5'-TCCTGCTTG TTACCTCGCT-3' 
5'-CCCAAGA TTCGTACCTGAA-3' 
5 ' -GCTGAGGTCACTCACCTGGA-3 ' 
(/ Two killds of sense primers were lIsed to :I 111plify eXOlt 7 of the 1'53 gene beca use tllis regio n l:Ontnil lCd a COI111110 11 polYlllorphic site as Sl1 0Wl1 in a p:lfcnlhcl' is 1.14 1. 
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Figure 1. lmmlll~ohi.tochemical detection o f p53 with CMl (a, c, e) 
and D07 ('"d) . a,b) Some stained nuclei arc present in the epidermis and 
tumor nests in a case ofBCC. c,lf) Sta incd nuclei are c1usterC!d in a small ar ea 
in the ep idcnTlis adjacent to BCC in another patient. c) Sta ined nucl ei arc 
scattered in thc nonnal epidermis w ith usual sun exposm e. Bar, 100 /Lm 
(a, b) and 50 /Lm (c,d,e) . 
the epidermis with C Ml and D07, respectively (Fig 1 and Table 
I). Unlike those in the epidermis adjacent to BCC, sta ined cells 
were scattered in the norm al epidermis in stead of forming a cluster. 
Of 11 specimens obtained from sites with rare sun exposure, on the 
other hand, only 2 (18%) showed nuclear staining in a few cells of 
the epidenll.is with C Ml, and none was stained wi.th D07 (Table I). 
In a subset of 13 different cases showing C M! sta ining in the 
epidermis (10 cases of normal skin with usual sun exposure and 
three cases ofBCC), mutations of the p53 gene were first screened 
by PCR-SSCP analysis. T hese 10 cases of norm al skin were chosen 
randomly from those older than 50 years of age. Three cases of 
BCC were se lected beca use epidermal portions sta in ed with C M 1 
were separated enough (more than 2 mm) from tumor nests, so th at 
DN As of epidermal portions showing CM 1 staining and those of 
tumor cells could be separa tely prepared wi thout cross-contamina-
tion. T he age of these three patients was, respectively 58, 63, and 
76 yea rs. T he epidermis adj acen t to BCC showed no histologic 
atypia in these three cases. No m obili ty shift in PCR-SSCP analysis 
was found in exons 2 to 10 of the p53 gene in 10 DN As of the 
normal epidermis w ith usual sun exposure. All three DNAs of the 
epidermis adjacent to BCC showed m obili ty shifts in ex on 7 (Fig 
2). DNA seq uencing of bands showing alte red migrations revealed 
a missense mutatio n of C to G transversion at a dipyriJ11idine site of 
codo n 249 in aU three DNAs, which replaced argin.ine with 
threonine (Fig 3). Presence of this mutation was supported by loss 
ofa HaelII site i.n DNAs showin g m o biJity shifts (data not shown). 
An analys is of a microsatcl li te marker (D11 S527) by PCR showed 
d ifFerent pattems in each DNA carrying the mutation (data not 
shown) . Therefore it was unl ike ly that the presence of the sam e 
mu tation in these three samples was ca used by cross-contamination. 
To rule o ut a possibiJi ty of contamination of PCR prod ucts, 
PCR-SSCP analys is of exon 7 was performed in the three cases 
using DNAs re-prepared fro m three tissue sections consecuti ve to 
1 
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Figure 2. SSCP analysis of ex on 7 of the p53 gene of three cases of 
BCC (.04, B, arrd q. Electrophoresis was performed ill an 8'1., po lyacryl-
amide gel containing 10% glycero l. Lalle 1, DNA from the ep idermis 
adj acent to BCC; lalle 2, BCC DNA; lau e 3. periphera l blood cell D NA. 
A rrol,vll cad. a band with a mobibty shi ft. 
those llsed for initi al DNA preparatio n. An abnormal band showi.ng 
a mobility shift was found in two of the three samples (data not 
shown) , indicating that at least two samples carried p53 mutation. 
In one of these three cases of BCC, tumor ceUs had a missense 
muta tio n of C to T transition at codon 177 in exon 5, which 
substituted le ucine for proline (data not shown). We have previ-
ously r epo rted this case [9] and confirmed here the presence of the 
muta ti o n in DNA obtained from a different portion of this BCe. 
No mutation was detected in exon 7 of these three DNAs fi'om 
Bee. 
DISCUSSION 
In this study, immunohistochemical p53 overexpression was fre-
quently detected in the normal epidermis with usual sun exposure 
cOlllpa red to that with rare sun exposure (p < 0.05). Similar results 
hav e been reported recently [23]. Nuclear accumul atio n of p53 in 
il'l vitro cultured cells was induced after treatment with DNA-
dartlaging agents including UV li ght irradiation [18] . R ecent ;11 1' ;110 
studi es also demonstrated p53 overexpression in the epidermis after 
acu te injury b y UV light irradiation [1 6,17]. Based on these, we 
hypothesize that chroni c inju ry by UV exposure in daily li fe is the 
main contributor to p53 accumul ation in normal epidermis with 
USl!a ] sun exposure . 
t\.lthough immunohistochemica l p53 overexpression is o ften 
correl.a ted with p53 gene mutations [13] , no mutation in exons 2 to 
10 of the p53 gene was detected here in the normal epidermis w ith 
chronjc sun exposure by PC R-SSCP analysis. Mutations of the p53 
gel'le in sun-exposed 110rmal skin have been reported recently using 
vety sensitive me thods of mutant aUele-specific PCR and mutant 
a lJ~le-specifi c ligase chain reaction [24]. T hese m ethods might 
detect mutations that are not clonaLly expanded and are present in 
cells i ncapable of growth. PC R-SSCP analysis used here is much 
less sensitive than these m ethods. T hereto re, o ur results do not 
necessariJy m ean the absence of p53 gene mutatio ns in normal 
epidermal cells with sun exposure, but do suggest rarity of clonal 
expafl sio n of p53 mu tant cells in the no rmal epide rmis with sun 
exposure. 
In the present study, accumulation of p53 was also frequent ly 
detected in the epidermi s adjacent to BCC de veloping on the fa ce 
that was usually sun-exposed. In the epide rmi s adjacent to BCC, 
uruike n orm al epidermis with usual sun exposure , a missense 
mlJta.tion of C to G transversion was found at codon 249 in exon 7 
of the p53 gene in three cases examined. This mutation was not due 
to an aUelic polymorphism, beca use it was not present in leukocyte 
DNAs of the patients. Detection of the mutatio n by PC R-SSC P 
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strongly suggested clonal expa nsion of p53 mutan t ce LI s in [h e 
epide rmis adj accnt to BCC of the three examin ed cases. T his clonal 
expansio n was li mited to a sm all area, because the mutation was not 
detected in o ne case using DNA re-prepared £:i'om portions close to 
those used for initial D NA preparation. Presence of a sm all cluster 
of stained cell s in the epidermis adj acent: to BCC m ay provide 
immuno histochemical evidence of sma ll cl onal expansio n of p53 
mutant cells. 
It is reasonabl e to speculate that the mutatio n may be relevant to 
slcin carcinoge nesis. firstly beca use codon 249 is located in aJl 
evolu tionari ly conserved domain of the p53 gene [4], secondly 
because this codo n is a mutational hotspot in hepatocellul ar ca r ci-
no mas [4]. and lastly because a mu ta n t p53 gene in this codon has 
been shown to induce mitotic activity in hepatoma cells [25]. 
Follow-up studies of patients with a history ofBCC have indicated 
that they have hi gh ri sk of developin g subsequen t new slcin can ccrs 
[26] . Presence of clonaLly expanded p53 mutant cells in t Ile 
epidermis of patients w ith BCC may provide a m o lecular bas is of 
the high risk. Altho ugh mutatio ns of codon 249 have been reported 
in three cases of skin ca ncers so far [6,9,27], the alterations do not 
appear to occur frequcntly in slcin cancers. T he discrepancy b e -
tween £:i'equent detection of the mu tation at codon 249 in t Il e 
epidermis adjacent to BCC and infrequent occurrence of tile 
mutatio n in slcin cancers rem ains to be answe red. 
It has previollsly been reported that the number of replicati(lg 
ceLI s are increased in the epidermis above BCC [28] . T his obser-
vation is consistent with the presence of p53 muta tio ns in t h e 
epidermis adj acent to BCC, because cells carrying certain p53 
mutant genes o bta in g rowth advantage by "gain of fun ctiot1 " 
[25,29J. 
All mu tatio ns detected in th e epidermis adj acent to BCC Were a 
missense mutatio n of C to G transversion at a dipyrimidine site of 
codon 249 of the p53 gene. Although occurrence of mutatio ns at a 
dipyrimidine site suggests in volvement of UV light in mutage ncsis 
[30], the two major types of DNA photoproducts . cyclobutane 
pyrim idine dimers and pyrimidin e(6-4)pyrimido ne photoproducts, 
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F igure 3. DNA sequences 
surrounding codon 249 in 
ex on 7 of the p53 gene. A, 
B, and C correspond to dIOse 
in Fig 2. Sequences of a sense 
strand and an antisense strand 
are sho wn in A . B, and C . 
respectively. Top, dle nomlal 
sequcnce of pcripheral leu-
kocyte DNA; bOt/Dill , mutated 
sequences of D N As from dle 
ep idennis aqjacent to BCC. 
ASIC";sk, dlC base at which 
mutation was detected. 
w hich are potentially mutage ni c [30], do not appear to be fre-
quently formcd at codon 249 of the p53 gene by UV i'Tadiation 
[31]. However, this does not necessarily indi cate lack of involve-
ment of UV light in mutagenesis at thi s site, because a UV-specific 
mutation of CC to TT tra nsition has been detected frequently at 
codons 245 and 247/ 248 in sun-exposed normal slcin [24], where 
the photoproducts are in £:i'eq uently formed [3 1] . Repair rates of 
pyrim idine d imers alo ng the p53 gene have been recently demon-
strated to be highly variable at individual nucleotides. A slow repai r 
rate at these sites may contribute to frequen t mutations [32]. 
Altho ugh pyrimidine dimers at codon 249 appear to be rapidly 
repaired in fibroblasts under conta ct inhibition [32], it will be the 
subject of future study to detcl"l11ine the repair rate at this site in the 
skin of patients w ith BCC. because repair capa citi es of UV-
damaged DNAs have been demonstrated to be reduced in the skin 
of pa tien ts w ith BCC l33]. Repair rates of the (6-4) photoproducts 
also remain to be determined at nucleotide resolution along the p53 
gene. 
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